Patient‐reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium
- 25 May 2020
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 95 (9), 1066-1074
- https://doi.org/10.1002/ajh.25880
Abstract
Understanding patient experiences, quality of life, and treatment needs in individuals with sickle cell disease (SCD) is essential in promoting health and well-being. We used measures from the Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me), Patient Reported Outcomes Measurement Information System (PROMIS), and Quality of Life in Neurological Disorders (NeuroQol) to evaluate pain impact, sleep impact, social functioning, depressive symptoms, tiredness, and cognitive function (collectively, patient reported outcomes [PROs]) and to identify associated demographic and clinical characteristics. Participants (n = 2201) between 18 and 45 years were recruited through the eight Sickle Cell Disease Implementation Consortium (SCDIC) sites. In multivariate models, PROs were significantly associated with one another. Pain impact was associated with age, education, employment, time since last pain attack, hydroxyurea use, opioid use, sleep impact, social functioning, and cognitive function (F = 88.74, P < .0001). Sleep impact was associated with household income, opioid use, pain impact, social functioning, depressive symptoms, and tiredness (F = 101.40, P < .0001). Social functioning was associated with employment, pain attacks in the past year, autoimmune/inflammatory comorbidities, pain impact, sleep impact, depressive symptoms, tiredness, and cognitive function (F = 121.73, P < .0001). Depressive symptoms were associated with sex, sleep impact, social functioning, tiredness, and cognitive function (F = 239.51, P < .0001). Tiredness was associated with sex, education, sleep impact, social functioning, depressive symptoms, and cognitive function (F = 129.13, P < .0001). These findings reflect the baseline PRO assessments among SCDIC registry participants. Further research is needed to better understand these outcomes and new targets for interventions to improve quality of life and function in people with SCD.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (HL133948, HL133964, HL133990, HL133994, HL133996, HL133997, HL134004, HL134007, HL134042)
This publication has 33 references indexed in Scilit:
- Fatigue in adolescents and young adults with sickle cell disease: biological and behavioral correlates and health-related quality of life.Journal of Pediatric Oncology Nursing, 2013
- Health‐related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT)Pediatric Blood & Cancer, 2011
- Somatic Symptom Burden in Adults with Sickle Cell Disease Predicts Pain, Depression, Anxiety, Health Care Utilization, and Quality of Life: The PiSCES ProjectPsychosomatics, 2011
- Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panelJournal of Clinical Epidemiology, 2010
- Health‐related quality of life in adults with sickle cell disease (SCD): A report from the comprehensive sickle cell centers clinical trial consortiumAmerican Journal of Hematology, 2010
- Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell AnemiaJAMA, 2010
- Population Estimates of Sickle Cell Disease in the U.S.American Journal of Preventive Medicine, 2010
- Daily Functioning and Quality of Life in Children With Sickle Cell Disease Pain: Relationship With Family and Neighborhood Socioeconomic DistressThe Journal of Pain, 2008
- DETECTION AND ASSESSMENT OF STROKE IN PATIENTS WITH SICKLE CELL DISEASE: Neuropsychological Functioning and Magnetic Resonance ImagingPediatric Hematology and Oncology, 2008
- Role of Adhesion Molecules and Vascular Endothelium in the Pathogenesis of Sickle Cell DiseaseHematology, 2007